Inventor

NARQUIZIAN ROBERT

FR45 patents

⚠️ This page may combine multiple inventors who share the name “NARQUIZIAN ROBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NARQUIZIAN ROBERT

HOFFMANN LA ROCHE

Pyrido [2,1-a] isoquinoline derivatives

Bi- and tricyclic substituted phenyl methanones

Pyrido[2,1-A]Isoquinoline derivatives

Monocyclic substituted phenyl methanones

Substituted acylpiperazine derivatives

Benzoyl-piperazine derivatives

Pyrido [2,1-a] isoquinoline derivatives

Pyrido[2,1-a]isoquinoline derivatives

Benzoyl-piperazine derivatives

CB 1 receptor inverse agonists

Heterocyclic-substituted phenyl methanones

Substituted phenyl methanone derivatives

Substituted phenyl methanone derivatives

Benzoyl-piperazine derivatives

Inhibitors for GlyT-1

4-amino-1,5-substituted-1,5-dihydro-imidazol-2-ones

Benzoyl-tetrahydropiperidine derivatives

Phenyl-piperazine methanone derivatives, substituted by heterocyclic groups

Phenyl-piperazine methanone derivatives, substituted by heterocyclic groups

Aminocycloalkanes as DPP-IV inhibitors

Aza-pyridopyrimidinone derivatives

Thiophene derivatives which are HM74A agonists

Anthranilic acid derivatives

Benzoyl-piperazine derivatives

CB 1 receptor inverse agonists

Pyrrolyl-thiazole derivatives

Di-aromatic substituted amides as inhibitors for GlyT-1

Substituted phenyl methanones

Amines or amino alcohols as GLYT1 inhibitors

Heterocyclic cannabinoid receptor antagonists

Pyridopyrimidinone derivatives which are HM74A agonists

4,5-dihydro-oxazol-2-yl amine derivatives

BANNER DAVID

2-amino-5,5-difluoro-5,6-dihydro-4H-[1,3]oxazin-4-yl)-phenyl]-amides

2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds

1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds

ANDREINI MATTEO

1,4 oxazines as BACE1 and/or BACE2 inhibitors

3-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines

1,4 oxazines as BACE1 and/or BACE2 inhibitors

HILPERT HANS

1,4-Oxazepines as BACE1 and/or BACE2 inhibitors

1,3-oxazines as BACE 1 and/or BACE2 inhibitors

NARQUIZIAN ROBERT

1,4-Oxazepines as BACE1 and/or BACE2 inhibitors

Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as BACE1 and/or BACE2 inhibitors

JOLIDON SYNESE

Heterocyclic-substituted phenyl methanones

BORONI EDILIO

[1,3]oxazines

KOLCZEWSKI SABINE

GlyT1 receptor antagonists